Saypha Lips Lidocaine

Saypha Lips Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, consisting of cross-linked hyaluronic acid obtained from Streptococcus equi bacteria, supplemented with lidocaine hydrochloride and phosphate buffered at pH 6,7 to 7,3. It contains 2,3% sodium hyaluronate, equivalent to 23 mg/mL, with lidocaine HCl 0,3%.

It is indicated to correct moderate to severe nasolabial folds and for lip augmentation, and must be injected into the mid to deep dermis or submucosa. Each box contains one pre-filled 1,0 mL syringe with two 27G 1/2 inch needles, three patient record labels and instructions for use including the international implant card. A 25G x 2 inch or 22G x 2 3/4 inch cannula may be affixed instead of the needle.

• Indicated for lip augmentation and for correcting moderate to severe nasolabial folds
• Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
• Contains lidocaine hydrochloride 0,3%, which reduces pain and discomfort during injection
• Can be delivered by needle or by cannula, a 25G x 2 inch or 22G x 2 3/4 inch
• Cross-linked to a mean degree of 0,5 to 1,0% with a typical particle size of approximately 316 micrometres
• BDDE cross-linking agent present at 2 ppm or less
• Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
• Manufactured by Croma-Pharma in Austria

Indications and Professional Use

Main indications

• Lip augmentation, to make the lips fuller
• Moderate to severe nasolabial folds, the deep lines running from the edge of the nose to the outer corners of the mouth
• For adults aged 18 or older; not to be used in people under the age of 18

Professional use

Saypha Lips Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa, using the supplied 27G 1/2 inch needle or, where the practitioner prefers, a 25G x 2 inch or 22G x 2 3/4 inch cannula. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4,5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.

Treatment areas

• Lips, by submucosal injection
• Nasolabial folds, by mid to deep dermis injection

Patient profile

For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

How Saypha Lips Lidocaine Works

Why Order From Allpara

Allpara offers genuine, verified SAYPHA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions